The 2003 Yu-Gi-Oh! Labyrinth of Nightmare Bio-Mage card (LON-043) is a Common rarity inclusion from the early LON set.
Bio-Mage
2003 • Yu-Gi-Oh! • Labyrinth of Nightmare
No Listings Available
No listings available right now.
Price History
Description
The Bio-Mage card, cataloged as LON-043, is a standard Common rarity card from the 2003 Yu-Gi-Oh! Labyrinth of Nightmare expansion. Released during the formative years of the Yu-Gi-Oh! Trading card game, this card represents the foundational era of collectible card design that established the franchise's enduring appeal. Collectors often seek out LON-043 to complete their sets of the Labyrinth of Nightmare series, which remains a notable chapter in the game's history. As a Common card, LON-043 serves as a staple for players looking to build out their decks with essential resources. For the serious collector, acquiring this card number is a key step in owning a complete run of the 2003 Labyrinth of Nightmare release. Whether you are a long-time fan of the Yu-Gi-Oh! TCG or a new enthusiast exploring early sets, LON-043 offers a tangible connection to the game's origins. The Labyrinth of Nightmare series continues to be a favorite among those who appreciate the evolution of the Yu-Gi-Oh! Brand and its impact on the broader trading card hobby.
Have one of these to sell?
We'll pre-fill the product details from this catalog entry, so your listing lands on this exact page. Just add photos of your copy, pick its condition, and set your price.
Card Details
The catalog profile below summarizes the card identity, featured subject, and notable collectible traits.
Catalog Profile
The core identity of the card within the set.
Featured Subject
The subject, team, league, and sport context tied to this card.
Featured
Bio-Mage
Game
Yu-Gi-Oh!
TCG Attributes
Rarity, print treatment, and game-specific stats for this card.
Common
Card Stock
English
Light
Fairy
3
1150 / 1000
Card Text
Abilities, attacks, oracle text, and flavor text printed on the card.
A mysterious priest created as a result of the latest advances in biotechnology.
